nodes	percent_of_prediction	percent_of_DWPC	metapath
Midodrine—SLC15A1—Lisinopril—dilated cardiomyopathy	0.803	1	CbGbCtD
Midodrine—Cramps of lower extremities—Spironolactone—dilated cardiomyopathy	0.00592	0.045	CcSEcCtD
Midodrine—ADRA1D—Adrenoceptors—ADRB1—dilated cardiomyopathy	0.00392	0.0596	CbGpPWpGaD
Midodrine—Heartburn—Lisinopril—dilated cardiomyopathy	0.00382	0.0291	CcSEcCtD
Midodrine—Drug interaction—Furosemide—dilated cardiomyopathy	0.00378	0.0288	CcSEcCtD
Midodrine—Stevens-Johnson syndrome—Spironolactone—dilated cardiomyopathy	0.00357	0.0272	CcSEcCtD
Midodrine—ADRA1B—Adrenoceptors—ADRB1—dilated cardiomyopathy	0.00325	0.0495	CbGpPWpGaD
Midodrine—Cramps of lower extremities—Furosemide—dilated cardiomyopathy	0.00322	0.0245	CcSEcCtD
Midodrine—ADRA1D—Adrenoceptors—ADRB2—dilated cardiomyopathy	0.00318	0.0483	CbGpPWpGaD
Midodrine—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.00306	0.0233	CcSEcCtD
Midodrine—ADRA1A—Adrenoceptors—ADRB1—dilated cardiomyopathy	0.00289	0.044	CbGpPWpGaD
Midodrine—Drug interaction—Lisinopril—dilated cardiomyopathy	0.00284	0.0216	CcSEcCtD
Midodrine—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.00271	0.0206	CcSEcCtD
Midodrine—ADRA1B—Adrenoceptors—ADRB2—dilated cardiomyopathy	0.00264	0.0401	CbGpPWpGaD
Midodrine—Irritability—Furosemide—dilated cardiomyopathy	0.00243	0.0185	CcSEcCtD
Midodrine—Urinary retention—Furosemide—dilated cardiomyopathy	0.00242	0.0184	CcSEcCtD
Midodrine—ADRA1A—Adrenoceptors—ADRB2—dilated cardiomyopathy	0.00234	0.0356	CbGpPWpGaD
Midodrine—Confusional state—Spironolactone—dilated cardiomyopathy	0.00232	0.0176	CcSEcCtD
Midodrine—Sleep disorder—Lisinopril—dilated cardiomyopathy	0.00221	0.0168	CcSEcCtD
Midodrine—Hepatic function abnormal—Lisinopril—dilated cardiomyopathy	0.00218	0.0166	CcSEcCtD
Midodrine—Somnolence—Spironolactone—dilated cardiomyopathy	0.00204	0.0155	CcSEcCtD
Midodrine—Pollakiuria—Furosemide—dilated cardiomyopathy	0.00203	0.0155	CcSEcCtD
Midodrine—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00198	0.0151	CcSEcCtD
Midodrine—Stevens-Johnson syndrome—Furosemide—dilated cardiomyopathy	0.00194	0.0148	CcSEcCtD
Midodrine—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00189	0.0144	CcSEcCtD
Midodrine—Hepatobiliary disease—Furosemide—dilated cardiomyopathy	0.00185	0.0141	CcSEcCtD
Midodrine—Irritability—Lisinopril—dilated cardiomyopathy	0.00182	0.0139	CcSEcCtD
Midodrine—Urinary tract disorder—Furosemide—dilated cardiomyopathy	0.00174	0.0132	CcSEcCtD
Midodrine—Urethral disorder—Furosemide—dilated cardiomyopathy	0.00173	0.0131	CcSEcCtD
Midodrine—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.00166	0.0127	CcSEcCtD
Midodrine—Pruritus—Spironolactone—dilated cardiomyopathy	0.00163	0.0124	CcSEcCtD
Midodrine—Angiopathy—Furosemide—dilated cardiomyopathy	0.0016	0.0122	CcSEcCtD
Midodrine—Dysuria—Lisinopril—dilated cardiomyopathy	0.00154	0.0117	CcSEcCtD
Midodrine—Dizziness—Spironolactone—dilated cardiomyopathy	0.00152	0.0116	CcSEcCtD
Midodrine—Flatulence—Furosemide—dilated cardiomyopathy	0.00151	0.0115	CcSEcCtD
Midodrine—Muscle spasms—Furosemide—dilated cardiomyopathy	0.00147	0.0112	CcSEcCtD
Midodrine—Stevens-Johnson syndrome—Lisinopril—dilated cardiomyopathy	0.00146	0.0111	CcSEcCtD
Midodrine—Rash—Spironolactone—dilated cardiomyopathy	0.00145	0.011	CcSEcCtD
Midodrine—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00145	0.011	CcSEcCtD
Midodrine—Headache—Spironolactone—dilated cardiomyopathy	0.00144	0.011	CcSEcCtD
Midodrine—Agitation—Furosemide—dilated cardiomyopathy	0.00141	0.0107	CcSEcCtD
Midodrine—Hepatobiliary disease—Lisinopril—dilated cardiomyopathy	0.00139	0.0106	CcSEcCtD
Midodrine—ADRA1D—Monoamine GPCRs—ADRB1—dilated cardiomyopathy	0.00139	0.0211	CbGpPWpGaD
Midodrine—Nausea—Spironolactone—dilated cardiomyopathy	0.00137	0.0104	CcSEcCtD
Midodrine—Bradycardia—Lisinopril—dilated cardiomyopathy	0.00134	0.0102	CcSEcCtD
Midodrine—Urinary tract disorder—Lisinopril—dilated cardiomyopathy	0.0013	0.00992	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.0013	0.00986	CcSEcCtD
Midodrine—Urethral disorder—Lisinopril—dilated cardiomyopathy	0.00129	0.00985	CcSEcCtD
Midodrine—Dry mouth—Furosemide—dilated cardiomyopathy	0.00128	0.00971	CcSEcCtD
Midodrine—Confusional state—Furosemide—dilated cardiomyopathy	0.00126	0.00959	CcSEcCtD
Midodrine—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.00125	0.0095	CcSEcCtD
Midodrine—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.00123	0.00933	CcSEcCtD
Midodrine—Flushing—Lisinopril—dilated cardiomyopathy	0.00123	0.00933	CcSEcCtD
Midodrine—Skin disorder—Furosemide—dilated cardiomyopathy	0.00121	0.00924	CcSEcCtD
Midodrine—Angiopathy—Lisinopril—dilated cardiomyopathy	0.0012	0.00912	CcSEcCtD
Midodrine—Chills—Lisinopril—dilated cardiomyopathy	0.00119	0.00902	CcSEcCtD
Midodrine—ADRA1D—Amine ligand-binding receptors—ADRB1—dilated cardiomyopathy	0.00117	0.0177	CbGpPWpGaD
Midodrine—Mental disorder—Lisinopril—dilated cardiomyopathy	0.00116	0.0088	CcSEcCtD
Midodrine—ADRA1B—Monoamine GPCRs—ADRB1—dilated cardiomyopathy	0.00115	0.0175	CbGpPWpGaD
Midodrine—Flatulence—Lisinopril—dilated cardiomyopathy	0.00113	0.00862	CcSEcCtD
Midodrine—Tension—Lisinopril—dilated cardiomyopathy	0.00113	0.00858	CcSEcCtD
Midodrine—ADRA1D—Monoamine GPCRs—ADRB2—dilated cardiomyopathy	0.00112	0.0171	CbGpPWpGaD
Midodrine—Paraesthesia—Furosemide—dilated cardiomyopathy	0.00112	0.00854	CcSEcCtD
Midodrine—Nervousness—Lisinopril—dilated cardiomyopathy	0.00112	0.0085	CcSEcCtD
Midodrine—Back pain—Lisinopril—dilated cardiomyopathy	0.00111	0.00846	CcSEcCtD
Midodrine—Somnolence—Furosemide—dilated cardiomyopathy	0.00111	0.00846	CcSEcCtD
Midodrine—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.00111	0.00841	CcSEcCtD
Midodrine—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.00108	0.00822	CcSEcCtD
Midodrine—Pain—Furosemide—dilated cardiomyopathy	0.00107	0.00814	CcSEcCtD
Midodrine—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00103	0.00784	CcSEcCtD
Midodrine—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00102	0.00778	CcSEcCtD
Midodrine—ADRA1A—Monoamine GPCRs—ADRB1—dilated cardiomyopathy	0.00102	0.0156	CbGpPWpGaD
Midodrine—ADRA1A—Endothelin Pathways—ADRB1—dilated cardiomyopathy	0.00102	0.0156	CbGpPWpGaD
Midodrine—Abdominal pain—Furosemide—dilated cardiomyopathy	0.000989	0.00752	CcSEcCtD
Midodrine—Anxiety—Lisinopril—dilated cardiomyopathy	0.000975	0.00742	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.000972	0.0074	CcSEcCtD
Midodrine—ADRA1B—Amine ligand-binding receptors—ADRB1—dilated cardiomyopathy	0.000967	0.0147	CbGpPWpGaD
Midodrine—Dry mouth—Lisinopril—dilated cardiomyopathy	0.000957	0.00728	CcSEcCtD
Midodrine—Confusional state—Lisinopril—dilated cardiomyopathy	0.000946	0.0072	CcSEcCtD
Midodrine—ADRA1D—Amine ligand-binding receptors—ADRB2—dilated cardiomyopathy	0.000944	0.0144	CbGpPWpGaD
Midodrine—ADRA1B—Monoamine GPCRs—ADRB2—dilated cardiomyopathy	0.000932	0.0142	CbGpPWpGaD
Midodrine—Tachycardia—Lisinopril—dilated cardiomyopathy	0.000916	0.00697	CcSEcCtD
Midodrine—Skin disorder—Lisinopril—dilated cardiomyopathy	0.000911	0.00694	CcSEcCtD
Midodrine—Asthenia—Furosemide—dilated cardiomyopathy	0.000897	0.00683	CcSEcCtD
Midodrine—Pruritus—Furosemide—dilated cardiomyopathy	0.000885	0.00673	CcSEcCtD
Midodrine—ADRA1D—Calcium Regulation in the Cardiac Cell—RYR2—dilated cardiomyopathy	0.000877	0.0134	CbGpPWpGaD
Midodrine—ADRA1A—Amine ligand-binding receptors—ADRB1—dilated cardiomyopathy	0.000859	0.0131	CbGpPWpGaD
Midodrine—ADRA1D—Calcium Regulation in the Cardiac Cell—PLN—dilated cardiomyopathy	0.000854	0.013	CbGpPWpGaD
Midodrine—Insomnia—Lisinopril—dilated cardiomyopathy	0.000849	0.00646	CcSEcCtD
Midodrine—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.000843	0.00641	CcSEcCtD
Midodrine—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000837	0.00637	CcSEcCtD
Midodrine—Somnolence—Lisinopril—dilated cardiomyopathy	0.000834	0.00635	CcSEcCtD
Midodrine—ADRA1A—Monoamine GPCRs—ADRB2—dilated cardiomyopathy	0.000828	0.0126	CbGpPWpGaD
Midodrine—Dizziness—Furosemide—dilated cardiomyopathy	0.000827	0.00629	CcSEcCtD
Midodrine—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.000826	0.00628	CcSEcCtD
Midodrine—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.00081	0.00616	CcSEcCtD
Midodrine—Pain—Lisinopril—dilated cardiomyopathy	0.000802	0.00611	CcSEcCtD
Midodrine—Rash—Furosemide—dilated cardiomyopathy	0.000788	0.006	CcSEcCtD
Midodrine—Dermatitis—Furosemide—dilated cardiomyopathy	0.000788	0.00599	CcSEcCtD
Midodrine—ADRA1B—Amine ligand-binding receptors—ADRB2—dilated cardiomyopathy	0.000783	0.0119	CbGpPWpGaD
Midodrine—Headache—Furosemide—dilated cardiomyopathy	0.000783	0.00596	CcSEcCtD
Midodrine—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000773	0.00588	CcSEcCtD
Midodrine—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.000767	0.00584	CcSEcCtD
Midodrine—SLC15A1—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000766	0.0117	CbGpPWpGaD
Midodrine—Nausea—Furosemide—dilated cardiomyopathy	0.000743	0.00565	CcSEcCtD
Midodrine—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000742	0.00564	CcSEcCtD
Midodrine—ADRA1B—Calcium Regulation in the Cardiac Cell—RYR2—dilated cardiomyopathy	0.000728	0.0111	CbGpPWpGaD
Midodrine—ADRA1B—Calcium Regulation in the Cardiac Cell—PLN—dilated cardiomyopathy	0.000708	0.0108	CbGpPWpGaD
Midodrine—ADRA1D—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.000707	0.0108	CbGpPWpGaD
Midodrine—ADRA1A—Amine ligand-binding receptors—ADRB2—dilated cardiomyopathy	0.000696	0.0106	CbGpPWpGaD
Midodrine—CYP2D6—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.000686	0.0104	CbGpPWpGaD
Midodrine—Asthenia—Lisinopril—dilated cardiomyopathy	0.000673	0.00512	CcSEcCtD
Midodrine—Pruritus—Lisinopril—dilated cardiomyopathy	0.000664	0.00505	CcSEcCtD
Midodrine—ADRA1A—Calcium Regulation in the Cardiac Cell—RYR2—dilated cardiomyopathy	0.000647	0.00984	CbGpPWpGaD
Midodrine—ADRA1D—GPCRs, Other—CXCR3—dilated cardiomyopathy	0.000636	0.00967	CbGpPWpGaD
Midodrine—ADRA1A—Calcium Regulation in the Cardiac Cell—PLN—dilated cardiomyopathy	0.000629	0.00958	CbGpPWpGaD
Midodrine—Dizziness—Lisinopril—dilated cardiomyopathy	0.00062	0.00472	CcSEcCtD
Midodrine—Rash—Lisinopril—dilated cardiomyopathy	0.000592	0.0045	CcSEcCtD
Midodrine—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000591	0.0045	CcSEcCtD
Midodrine—Headache—Lisinopril—dilated cardiomyopathy	0.000588	0.00447	CcSEcCtD
Midodrine—ADRA1B—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.000587	0.00894	CbGpPWpGaD
Midodrine—Nausea—Lisinopril—dilated cardiomyopathy	0.000557	0.00424	CcSEcCtD
Midodrine—ADRA1A—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.000522	0.00794	CbGpPWpGaD
Midodrine—ADRA1D—GPCRs, Other—ADRB2—dilated cardiomyopathy	0.000499	0.00759	CbGpPWpGaD
Midodrine—ADRA1D—G alpha (12/13) signalling events—RAC1—dilated cardiomyopathy	0.000452	0.00688	CbGpPWpGaD
Midodrine—ADRA1B—AMPK Signaling—RPS6KB1—dilated cardiomyopathy	0.000444	0.00676	CbGpPWpGaD
Midodrine—ADRA1A—Endothelin Pathways—RAF1—dilated cardiomyopathy	0.000426	0.00649	CbGpPWpGaD
Midodrine—ADRA1B—LPA receptor mediated events—RAC1—dilated cardiomyopathy	0.000426	0.00648	CbGpPWpGaD
Midodrine—ADRA1D—Calcium Regulation in the Cardiac Cell—ADRB1—dilated cardiomyopathy	0.000415	0.00632	CbGpPWpGaD
Midodrine—SLC15A1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.0004	0.00609	CbGpPWpGaD
Midodrine—ADRA1A—AMPK Signaling—RPS6KB1—dilated cardiomyopathy	0.000394	0.006	CbGpPWpGaD
Midodrine—SLC15A1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000389	0.00592	CbGpPWpGaD
Midodrine—SLC15A1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000389	0.00592	CbGpPWpGaD
Midodrine—ADRA1B—G alpha (12/13) signalling events—RAC1—dilated cardiomyopathy	0.000375	0.00571	CbGpPWpGaD
Midodrine—SLC15A1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000362	0.00551	CbGpPWpGaD
Midodrine—ADRA1B—Calcium Regulation in the Cardiac Cell—ADRB1—dilated cardiomyopathy	0.000344	0.00524	CbGpPWpGaD
Midodrine—ADRA1D—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	0.000343	0.00521	CbGpPWpGaD
Midodrine—ADRA1D—Calcium Regulation in the Cardiac Cell—ADRB2—dilated cardiomyopathy	0.000336	0.00512	CbGpPWpGaD
Midodrine—ADRA1A—G alpha (12/13) signalling events—RAC1—dilated cardiomyopathy	0.000333	0.00507	CbGpPWpGaD
Midodrine—ADRA1A—Calcium Regulation in the Cardiac Cell—ADRB1—dilated cardiomyopathy	0.000306	0.00466	CbGpPWpGaD
Midodrine—ADRA1D—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.000297	0.00452	CbGpPWpGaD
Midodrine—ADRA1D—G alpha (q) signalling events—AGTR1—dilated cardiomyopathy	0.000296	0.0045	CbGpPWpGaD
Midodrine—ADRA1B—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	0.000284	0.00433	CbGpPWpGaD
Midodrine—ADRA1B—Calcium Regulation in the Cardiac Cell—ADRB2—dilated cardiomyopathy	0.000279	0.00425	CbGpPWpGaD
Midodrine—ADRA1D—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.000276	0.0042	CbGpPWpGaD
Midodrine—ADRA1D—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.000267	0.00407	CbGpPWpGaD
Midodrine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—dilated cardiomyopathy	0.000264	0.00402	CbGpPWpGaD
Midodrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.000255	0.00387	CbGpPWpGaD
Midodrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.000255	0.00387	CbGpPWpGaD
Midodrine—ADRA1A—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	0.000253	0.00384	CbGpPWpGaD
Midodrine—ADRA1A—Calcium Regulation in the Cardiac Cell—ADRB2—dilated cardiomyopathy	0.000248	0.00377	CbGpPWpGaD
Midodrine—ADRA1B—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.000247	0.00375	CbGpPWpGaD
Midodrine—ADRA1B—G alpha (q) signalling events—AGTR1—dilated cardiomyopathy	0.000245	0.00373	CbGpPWpGaD
Midodrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000237	0.0036	CbGpPWpGaD
Midodrine—ADRA1B—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.000229	0.00349	CbGpPWpGaD
Midodrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000229	0.00349	CbGpPWpGaD
Midodrine—ADRA1D—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000228	0.00348	CbGpPWpGaD
Midodrine—ADRA1B—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.000222	0.00338	CbGpPWpGaD
Midodrine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—dilated cardiomyopathy	0.000219	0.00334	CbGpPWpGaD
Midodrine—ADRA1A—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.000219	0.00333	CbGpPWpGaD
Midodrine—ADRA1A—G alpha (q) signalling events—AGTR1—dilated cardiomyopathy	0.000218	0.00332	CbGpPWpGaD
Midodrine—ADRA1D—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000217	0.0033	CbGpPWpGaD
Midodrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.000211	0.00321	CbGpPWpGaD
Midodrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.000211	0.00321	CbGpPWpGaD
Midodrine—ADRA1D—G alpha (q) signalling events—AGT—dilated cardiomyopathy	0.000208	0.00316	CbGpPWpGaD
Midodrine—ADRA1A—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.000204	0.0031	CbGpPWpGaD
Midodrine—ADRA1A—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.000197	0.003	CbGpPWpGaD
Midodrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000196	0.00299	CbGpPWpGaD
Midodrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000196	0.00298	CbGpPWpGaD
Midodrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—dilated cardiomyopathy	0.000195	0.00297	CbGpPWpGaD
Midodrine—ADRA1D—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000194	0.00295	CbGpPWpGaD
Midodrine—ADRA1D—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000194	0.00295	CbGpPWpGaD
Midodrine—ADRA1B—LPA receptor mediated events—EGFR—dilated cardiomyopathy	0.000194	0.00295	CbGpPWpGaD
Midodrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00019	0.00289	CbGpPWpGaD
Midodrine—ADRA1B—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00019	0.00289	CbGpPWpGaD
Midodrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.000188	0.00286	CbGpPWpGaD
Midodrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.000188	0.00286	CbGpPWpGaD
Midodrine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.000186	0.00283	CbGpPWpGaD
Midodrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000186	0.00283	CbGpPWpGaD
Midodrine—ADRA1D—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00018	0.00274	CbGpPWpGaD
Midodrine—ADRA1B—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00018	0.00274	CbGpPWpGaD
Midodrine—ADRA1D—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000175	0.00266	CbGpPWpGaD
Midodrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000174	0.00265	CbGpPWpGaD
Midodrine—ADRA1B—G alpha (q) signalling events—AGT—dilated cardiomyopathy	0.000173	0.00263	CbGpPWpGaD
Midodrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000169	0.00257	CbGpPWpGaD
Midodrine—ADRA1A—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000168	0.00256	CbGpPWpGaD
Midodrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000162	0.00247	CbGpPWpGaD
Midodrine—ADRA1B—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000161	0.00245	CbGpPWpGaD
Midodrine—ADRA1B—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000161	0.00245	CbGpPWpGaD
Midodrine—ADRA1A—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00016	0.00243	CbGpPWpGaD
Midodrine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.000154	0.00235	CbGpPWpGaD
Midodrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000154	0.00235	CbGpPWpGaD
Midodrine—ADRA1A—G alpha (q) signalling events—AGT—dilated cardiomyopathy	0.000153	0.00233	CbGpPWpGaD
Midodrine—ADRA1B—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00015	0.00228	CbGpPWpGaD
Midodrine—ADRA1D—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000149	0.00227	CbGpPWpGaD
Midodrine—ADRA1B—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000145	0.0022	CbGpPWpGaD
Midodrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000144	0.0022	CbGpPWpGaD
Midodrine—ADRA1A—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000143	0.00217	CbGpPWpGaD
Midodrine—ADRA1A—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000143	0.00217	CbGpPWpGaD
Midodrine—ADRA1D—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000141	0.00215	CbGpPWpGaD
Midodrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000138	0.0021	CbGpPWpGaD
Midodrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.000137	0.00209	CbGpPWpGaD
Midodrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000137	0.00208	CbGpPWpGaD
Midodrine—ADRA1A—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000133	0.00202	CbGpPWpGaD
Midodrine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.000129	0.00196	CbGpPWpGaD
Midodrine—ADRA1A—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000129	0.00196	CbGpPWpGaD
Midodrine—ADRA1B—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000124	0.00188	CbGpPWpGaD
Midodrine—ADRA1B—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000117	0.00179	CbGpPWpGaD
Midodrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000114	0.00174	CbGpPWpGaD
Midodrine—ADRA1A—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00011	0.00167	CbGpPWpGaD
Midodrine—ADRA1D—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.00011	0.00167	CbGpPWpGaD
Midodrine—ADRA1D—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.00011	0.00167	CbGpPWpGaD
Midodrine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.000107	0.00163	CbGpPWpGaD
Midodrine—ADRA1D—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000105	0.0016	CbGpPWpGaD
Midodrine—ADRA1A—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000104	0.00159	CbGpPWpGaD
Midodrine—ADRA1D—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000102	0.00155	CbGpPWpGaD
Midodrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000102	0.00155	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—AGTR2—dilated cardiomyopathy	9.95e-05	0.00151	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—CXCL2—dilated cardiomyopathy	9.95e-05	0.00151	CbGpPWpGaD
Midodrine—ADRA1D—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	9.86e-05	0.0015	CbGpPWpGaD
Midodrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	9.52e-05	0.00145	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—CXCR3—dilated cardiomyopathy	9.25e-05	0.00141	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	9.09e-05	0.00138	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	9.09e-05	0.00138	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—ADRB1—dilated cardiomyopathy	8.96e-05	0.00136	CbGpPWpGaD
Midodrine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	8.85e-05	0.00135	CbGpPWpGaD
Midodrine—ADRA1B—GPCR ligand binding—AGT—dilated cardiomyopathy	8.7e-05	0.00132	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	8.45e-05	0.00129	CbGpPWpGaD
Midodrine—ADRA1D—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	8.42e-05	0.00128	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—ANKRD1—dilated cardiomyopathy	8.38e-05	0.00128	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—AGTR2—dilated cardiomyopathy	8.26e-05	0.00126	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—CXCL2—dilated cardiomyopathy	8.26e-05	0.00126	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	8.19e-05	0.00125	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	8.08e-05	0.00123	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	8.08e-05	0.00123	CbGpPWpGaD
Midodrine—ADRA1D—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	7.99e-05	0.00122	CbGpPWpGaD
Midodrine—SLC15A1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	7.89e-05	0.0012	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—TAZ—dilated cardiomyopathy	7.88e-05	0.0012	CbGpPWpGaD
Midodrine—ADRA1A—GPCR ligand binding—AGT—dilated cardiomyopathy	7.73e-05	0.00118	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—CXCR3—dilated cardiomyopathy	7.67e-05	0.00117	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—AGTR1—dilated cardiomyopathy	7.65e-05	0.00116	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	7.51e-05	0.00114	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—ADRB1—dilated cardiomyopathy	7.43e-05	0.00113	CbGpPWpGaD
Midodrine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	7.35e-05	0.00112	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—AGTR2—dilated cardiomyopathy	7.33e-05	0.00112	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—CXCL2—dilated cardiomyopathy	7.33e-05	0.00112	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	7.27e-05	0.00111	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—ADRB2—dilated cardiomyopathy	7.26e-05	0.0011	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—SDHA—dilated cardiomyopathy	7.13e-05	0.00108	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	6.99e-05	0.00106	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—CXCR3—dilated cardiomyopathy	6.82e-05	0.00104	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	6.63e-05	0.00101	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—PSEN2—dilated cardiomyopathy	6.62e-05	0.00101	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—ADRB1—dilated cardiomyopathy	6.6e-05	0.001	CbGpPWpGaD
Midodrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	6.53e-05	0.000993	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—AGTR1—dilated cardiomyopathy	6.35e-05	0.000966	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	6.21e-05	0.000945	CbGpPWpGaD
Midodrine—ADRA1D—GPCR downstream signaling—RAC1—dilated cardiomyopathy	6.2e-05	0.000944	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—ADRB2—dilated cardiomyopathy	6.02e-05	0.000917	CbGpPWpGaD
Midodrine—ADRA1D—GPCR downstream signaling—AGT—dilated cardiomyopathy	5.93e-05	0.000902	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	5.89e-05	0.000896	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—CXCL2—dilated cardiomyopathy	5.88e-05	0.000894	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—AGTR2—dilated cardiomyopathy	5.88e-05	0.000894	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	5.64e-05	0.000858	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—RAC1—dilated cardiomyopathy	5.63e-05	0.000857	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—PSEN2—dilated cardiomyopathy	5.49e-05	0.000836	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—CXCR3—dilated cardiomyopathy	5.46e-05	0.000831	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—AGT—dilated cardiomyopathy	5.38e-05	0.000819	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	5.35e-05	0.000814	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—ADRB1—dilated cardiomyopathy	5.29e-05	0.000805	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—RAC1—dilated cardiomyopathy	5.15e-05	0.000784	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—AGT—dilated cardiomyopathy	4.92e-05	0.000749	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—PSEN2—dilated cardiomyopathy	4.88e-05	0.000742	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—CXCL2—dilated cardiomyopathy	4.88e-05	0.000742	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—AGTR2—dilated cardiomyopathy	4.88e-05	0.000742	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—RAC1—dilated cardiomyopathy	4.68e-05	0.000712	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	4.57e-05	0.000696	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—CXCR3—dilated cardiomyopathy	4.53e-05	0.00069	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—AGTR1—dilated cardiomyopathy	4.52e-05	0.000688	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—AGT—dilated cardiomyopathy	4.47e-05	0.00068	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—ADRB1—dilated cardiomyopathy	4.39e-05	0.000668	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—AGT—dilated cardiomyopathy	4.37e-05	0.000665	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—CXCL2—dilated cardiomyopathy	4.33e-05	0.000659	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—AGTR2—dilated cardiomyopathy	4.33e-05	0.000659	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—ADRB2—dilated cardiomyopathy	4.29e-05	0.000652	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—RAC1—dilated cardiomyopathy	4.15e-05	0.000632	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—CXCR3—dilated cardiomyopathy	4.03e-05	0.000613	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—AGT—dilated cardiomyopathy	3.97e-05	0.000604	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—ADRB1—dilated cardiomyopathy	3.9e-05	0.000594	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—AGTR1—dilated cardiomyopathy	3.75e-05	0.000571	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—RAF1—dilated cardiomyopathy	3.74e-05	0.000568	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	3.68e-05	0.000561	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—ADRB2—dilated cardiomyopathy	3.56e-05	0.000541	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—AGTR1—dilated cardiomyopathy	3.33e-05	0.000507	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—RAC1—dilated cardiomyopathy	3.33e-05	0.000506	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—AGT—dilated cardiomyopathy	3.18e-05	0.000484	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—ADRB2—dilated cardiomyopathy	3.16e-05	0.000481	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—RAF1—dilated cardiomyopathy	3.1e-05	0.000472	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	3.06e-05	0.000465	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—RAC1—dilated cardiomyopathy	2.76e-05	0.00042	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—RAF1—dilated cardiomyopathy	2.75e-05	0.000419	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.72e-05	0.000413	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—AGT—dilated cardiomyopathy	2.64e-05	0.000402	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.56e-05	0.00039	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—RAC1—dilated cardiomyopathy	2.45e-05	0.000373	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—AGT—dilated cardiomyopathy	2.34e-05	0.000357	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—RAF1—dilated cardiomyopathy	2.21e-05	0.000336	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.13e-05	0.000324	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—GPX1—dilated cardiomyopathy	1.94e-05	0.000295	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.89e-05	0.000287	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—CD36—dilated cardiomyopathy	1.89e-05	0.000287	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—RAF1—dilated cardiomyopathy	1.83e-05	0.000279	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—AGT—dilated cardiomyopathy	1.7e-05	0.000258	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—RAF1—dilated cardiomyopathy	1.63e-05	0.000248	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—EGFR—dilated cardiomyopathy	1.51e-05	0.00023	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—EGFR—dilated cardiomyopathy	1.26e-05	0.000191	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—EGFR—dilated cardiomyopathy	1.12e-05	0.00017	CbGpPWpGaD
